SE9901237D0 - Novel use - Google Patents

Novel use

Info

Publication number
SE9901237D0
SE9901237D0 SE9901237A SE9901237A SE9901237D0 SE 9901237 D0 SE9901237 D0 SE 9901237D0 SE 9901237 A SE9901237 A SE 9901237A SE 9901237 A SE9901237 A SE 9901237A SE 9901237 D0 SE9901237 D0 SE 9901237D0
Authority
SE
Sweden
Prior art keywords
hydrogen
fluorophenyl
phenyl
novel use
coch2nh2
Prior art date
Application number
SE9901237A
Other languages
Swedish (sv)
Inventor
Hans Basun
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9901237A priority Critical patent/SE9901237D0/en
Publication of SE9901237D0 publication Critical patent/SE9901237D0/en
Priority to AU39941/00A priority patent/AU3994100A/en
Priority to PCT/SE2000/000643 priority patent/WO2000059496A1/en
Priority to ARP000101558A priority patent/AR023389A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the use of low affinity NMDA antagonist for the treatment of headache. Preferred compounds include compounds of formula (I): wherein R<1> is pyridyl, phenyl or 4-fluorophenyl; R<2> is phenyl or 4-fluorophenyl; R<3> is hydrogen, C1-6 alkyl or methoxycarbonyl; R<4> is hydrogen or methyl; and R<5> is hydrogen or COCH2NH2.
SE9901237A 1999-04-06 1999-04-06 Novel use SE9901237D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9901237A SE9901237D0 (en) 1999-04-06 1999-04-06 Novel use
AU39941/00A AU3994100A (en) 1999-04-06 2000-04-04 Use of low affinity nmda antagonists for the treatment of headache
PCT/SE2000/000643 WO2000059496A1 (en) 1999-04-06 2000-04-04 Use of low affinity nmda antagonists for the treatment of headache
ARP000101558A AR023389A1 (en) 1999-04-06 2000-04-05 NEW USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901237A SE9901237D0 (en) 1999-04-06 1999-04-06 Novel use

Publications (1)

Publication Number Publication Date
SE9901237D0 true SE9901237D0 (en) 1999-04-06

Family

ID=20415133

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901237A SE9901237D0 (en) 1999-04-06 1999-04-06 Novel use

Country Status (4)

Country Link
AR (1) AR023389A1 (en)
AU (1) AU3994100A (en)
SE (1) SE9901237D0 (en)
WO (1) WO2000059496A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020052A1 (en) * 1992-04-03 1993-10-14 Fisons Corporation Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
SG52662A1 (en) * 1988-08-12 1998-09-28 Astra Ab Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties
DE69201141T2 (en) * 1991-02-28 1995-05-11 Merrell Dow Pharma NMDA antagonists.
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
WO1995006468A1 (en) * 1993-09-01 1995-03-09 Smithkline Beecham Corporation Method for treating migraine headaches
IS4233A (en) * 1993-12-22 1995-06-23 Astra Aktiebolag Misguided ring-related compounds
DE19510189A1 (en) * 1995-03-21 1996-09-26 Hartmut Dr Goebel Use of amantadine
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
EP1011656A2 (en) * 1996-11-05 2000-06-28 Head Explorer ApS A method for treating tension-type headache

Also Published As

Publication number Publication date
WO2000059496A1 (en) 2000-10-12
AU3994100A (en) 2000-10-23
AR023389A1 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
NL300877I2 (en) obeticholic acid
BR0114045A (en) Polyarylcarboxamides useful as lipid lowering agents
TR200102338T2 (en) Cyclic substituted linked pyrolocarbazoles and isoindolones.
NO20074657L (en) Nitrogen-containing aromatic ring compounds
NO20101069L (en) Use of certain NMDA affinity antagonists as antidepressants
GB9801690D0 (en) Therapeutic agents
NO20033385D0 (en) Fused heterocyclic compounds
NO20060314L (en) Nicotinamide derivatives useful as PDE4 inhibitors
DE60121461D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
DE60112306D1 (en) CONDENSED PYRAZINDION DERIVATIVES AS PDE5 INHIBITORS
DE69924292D1 (en) PYRAZOL COMPOUNDS AND ITS USE
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
BG105710A (en) 5ht1 antagonists for antidepressant therapy
ATE333457T1 (en) CYCLIC GMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS
DK1204658T3 (en) Benzofurylpiperazine-serotonin agonists
DE60041001D1 (en) SUBSTITUTED HOMOPIPERIDYLBENZIMIDAZOLANALOGA AS FUNDUSRELAXANTIA
DE60110124D1 (en) CONDENSED PYRAZINDION DERIVATIVES AS PDE INHIBITORS
DE60121048D1 (en) PYRAZINOi1&#39;2 &#39;: 1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE60222465D1 (en) PYRAZOLOPYRIDINE DERIVATIVES AS ANTI-HERPING AGENTS
ATE191465T1 (en) CARBAMOYLCARBONIC ACID AMIDES
NO20033049D0 (en) Process for the preparation of (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1
SE9704770D0 (en) New use
SE9901237D0 (en) Novel use
DE60110233D1 (en) NEW N- (2-PHENYL-3-AMINOPROPYL) NAPHTAMIDE
ATE366727T1 (en) DIARYL-1,2,4-TRIAZOLE DERIVATIVES AS HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITORS